This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of lip
CD2_INSITU_LIP
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519930 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ glandulae thyreoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of lip
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of lip, excluding all cancers
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 10 | 23 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 67.61 | 58.16 | 71.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
16
72
3.37
2.85
2.8
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
8
23
4.24
2.46
1.9
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
8
7.11
2.46
4.4
8.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
8
25
3.88
2.27
3.8
4.0
kpa
4.8
4.7
—
8
25
(3027801) Oxygen [Partial pressure] in Arterial blood
8
25
3.88
2.27
3.8
4.0
kpa
11.6
10.7
—
8
25
(3016502) Oxygen saturation in Arterial blood
8
25
3.88
2.27
4.0
4.2
%
92.0
94.9
—
8
25
(3000494) Fungus identified in Specimen by Culture
7
21
3.94
2.10
1.4
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
7
24
3.42
1.84
4.0
4.3
g/l
114.3
124.9
—
7
24
(3014007) Fractional oxyhemoglobin in Arterial blood
5
15
3.73
1.58
2.8
5.9
%
94.3
93.8
—
5
15
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
28
2.89
1.55
3.6
2.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
16
3.49
1.49
2.8
5.3
%
0.8
0.7
—
5
16
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
16
3.49
1.49
2.6
3.6
%
0.9
1.2
—
5
16
(3000991) Gas panel - Venous blood
5
17
3.27
1.41
4.0
6.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6
24
2.82
1.37
5.0
1.7
umol/l
45.7
4.2
—
6
19
(3023368) Bacteria identified in Blood by Culture
13
73
2.29
1.35
9.2
4.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
13
74
2.25
1.30
4.4
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
19
2.91
1.26
1.6
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
30
2.68
1.21
2.9
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
7
33
2.42
1.14
4.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
51
2.05
1.05
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
28
232
2.36
0.98
23.9
15.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
11
65
2.04
0.97
3.7
2.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
15
100
1.92
0.95
3.1
4.7
ng/l
39.0
42.2
—
10
81
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
15
100
1.92
0.95
6.6
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
23
181
1.89
0.84
35.8
18.2
%
34.6
39.0
0.57
11
111
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
23
2.38
0.80
1.4
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
25
2.17
0.76
7.8
9.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
42
1.84
0.74
3.6
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
28
1.92
0.69
1.8
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
50
1.79
0.68
3.0
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
8
50
1.79
0.68
5.1
4.3
—
1.0
—
0
6
(3020564) Creatinine [Moles/volume] in Serum or Plasma
27
233
1.87
0.65
35.0
19.7
umol/l
106.8
85.8
0.85
27
233
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
101
1.67
0.63
5.8
3.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
0
19
0.00
0.62
0.0
4.6
—
0.8
—
0
5
(3002385) Erythrocyte distribution width [Ratio]
22
180
1.67
0.60
37.8
20.5
%
14.0
13.9
0.07
22
173
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
13
94
1.63
0.57
2.0
2.4
nmol/l
77.7
74.4
0.18
13
85
(36304419) Bacteria [Presence] in Urine
11
81
1.54
0.43
4.7
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
16
0.00
0.42
0.0
1.6
—
—
—
0
0
(3013512) EKG study
5
77
0.59
0.42
3.4
5.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
0
17
0.00
0.42
0.0
4.6
—
1.6
—
0
5
(3002179) Metamyelocytes/100 leukocytes in Blood
0
18
0.00
0.41
0.0
4.5
—
0.8
—
0
5
(3021440) Promyelocytes/100 leukocytes in Blood
0
18
0.00
0.41
0.0
4.9
—
0.2
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
14
110
1.47
0.41
3.4
2.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
10
75
1.48
0.35
6.1
5.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
18
153
1.39
0.32
6.2
4.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
73
0.63
0.30
4.4
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
17
149
1.29
0.22
5.7
4.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
11
0.00
0.22
0.0
3.4
—
4.7
—
0
11
(3012501) Base excess in Blood by calculation
0
11
0.00
0.22
0.0
3.4
—
2.8
—
0
6
(3045414) Leukocytes [Presence] in Urine
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
11
0.00
0.22
0.0
3.4
—
8.6
—
0
11
(3010421) pH of Blood
0
11
0.00
0.22
0.0
3.7
—
7.4
—
0
11
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.0
—
26.2
—
0
5
(21494755) Public health laboratory ask at order entry panel
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
49
1.27
0.21
5.3
4.3
—
—
—
0
0
(3000492) Spirometry study
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5
66
0.71
0.19
1.2
1.4
mmol/l
2.0
1.3
—
5
58
(3000850) Epithelial cells [#/volume] in Urine
8
69
1.21
0.18
5.6
2.4
e6/l
2.4
4.8
—
8
60
(3015736) pH of Urine
10
83
1.29
0.18
5.0
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
12
106
1.21
0.12
2.0
2.2
pmol/l
116.4
89.7
—
6
60
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
5
47
1.08
0.10
1.2
1.6
mg/l
1.4
0.8
—
5
35
(3026493) Urate [Moles/volume] in Serum or Plasma
7
64
1.12
0.09
3.4
3.0
umol/l
326.3
10976.7
—
7
58
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
12
131
0.87
0.07
4.1
3.1
u/l
100.1
46.3
0.75
12
122
(40768800) Prostate Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
22.4
—
0
6
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
96
0.91
0.00
5.6
4.3
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.6
—
0
5
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
5
57
0.86
0.00
6.2
6.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.7
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
6
63
0.94
0.00
6.0
3.3
mosm/kgh2o
501.7
561.4
—
6
51
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_LIP – Carcinoma in situ of lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).